
Topic
Coverage Access
Formulary tiers, utilization management, patient support, and the access layer GoodRx and drug labels do not explain.

Pricing & Access· August 13, 2026 · 22 min read

Specialty· August 4, 2026 · 13 min read
Narcolepsy & Idiopathic Hypersomnia Access: Wakefulness to Oxybates
By Ran Chen#Specialty Pharmacy#REMS#Prior Authorization

Pricing & Access· June 10, 2026 · 10 min read
Bispecific antibody access landscape for myeloma and lymphoma

Pricing & Access· June 10, 2026 · 9 min read
CAR-T cell therapy access landscape: seven products in 2026
By Ran Chen#CAR-T#Oncology#Prior Authorization

Pricing & Access· June 10, 2026 · 10 min read
PD-1/PD-L1 checkpoint inhibitor access landscape in 2026

Pricing & Access· June 9, 2026 · 10 min read
Awiqli coverage guide: insulin icodec access, PA criteria, and Part D pricing

Policy· June 9, 2026 · 12 min read
IRA Medicare drug negotiation third cycle: 15 drugs selected for 2028

Pipeline· June 7, 2026 · 9 min read
Cytisinicline smoking cessation PDUFA preview: first new pharmacotherapy in 20 years
By Ran Chen#PDUFA Date#FDA Approval#Clinical Evidence

Approvals· June 7, 2026 · 8 min read
Imfinzi + BCG for NMIBC access guide: FDA approval, coding, and buy-and-bill
By Ran Chen#Oncology#PD-L1#Prior Authorization

Biosimilars· June 7, 2026 · 8 min read